Results
|
|
6241.
|
|
|
|
6242.
|
|
|
|
6243.
|
Fludarabine, cyclophosphamide, and rituximab in salvage therapy of Waldenström's macroglobulinemia. [electronic resource] by
- Tedeschi, Alessandra
- Ricci, Francesca
- Goldaniga, Maria Cecilia
- Benevolo, Giulia
- Varettoni, Marzia
- Motta, Marina
- Pioltelli, Pietro
- Gini, Guido
- Barate', Claudia
- Luraschi, Annamaria
- Vismara, Eleonora
- Frustaci, Anna Maria
- Nichelatti, Michele
- Vitolo, Umberto
- Baldini, Luca
- Morra, Enrica
Producer: 20131210
In:
Clinical lymphoma, myeloma & leukemia vol. 13
Availability: No items available.
|
|
|
6244.
|
Simultaneous presentation of Waldenström macroglobulinemia and multiple myeloma: multidisciplinary diagnosis, treatment and 30-month follow-up. [electronic resource] by
- Carulli, Giovanni
- Ciancia, Eugenio M
- Azzarà, Antonio
- Ottaviano, Virginia
- Grassi, Susanna
- Ciabatti, Elena
- Ferreri, Maria I
- Rocco, Melania
- Marini, Alessandra
- Petrini, Mario
Producer: 20140506
In:
Journal of clinical and experimental hematopathology : JCEH vol. 53
Availability: No items available.
|
|
|
6245.
|
Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab. [electronic resource] by
- García-Cadenas, I
- Castillo, N
- Martino, R
- Barba, P
- Esquirol, A
- Novelli, S
- Orti, G
- Garrido, A
- Saavedra, S
- Moreno, C
- Granell, M
- Briones, J
- Brunet, S
- Navarro, F
- Ruiz, I
- Rabella, N
- Valcárcel, D
- Sierra, J
Producer: 20151221
In:
Bone marrow transplantation vol. 50
Availability: No items available.
|
|
|
6246.
|
|
|
|
6247.
|
|
|
|
6248.
|
Phase I Clinical Trial of Intravenous L-ascorbic Acid Following Salvage Chemotherapy for Relapsed B-cell non-Hodgkin's Lymphoma. [electronic resource] by
- Kawada, Hiroshi
- Sawanobori, Masakazu
- Tsuma-Kaneko, Mitsuyo
- Wasada, Izumi
- Miyamoto, Mitsuki
- Murayama, Hiromichi
- Toyosaki, Masako
- Onizuka, Makoto
- Tsuboi, Kosuke
- Tazume, Kei
- Shirasugi, Yukari
- Ohmachi, Ken
- Ogawa, Yoshiaki
- Kobayashi, Hiroyuki
- Ando, Kiyoshi
Producer: 20160229
In:
The Tokai journal of experimental and clinical medicine vol. 39
Availability: No items available.
|
|
|
6249.
|
|
|
|
6250.
|
|
|
|
6251.
|
|
|
|
6252.
|
Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacy. [electronic resource] by
- Lew, Thomas E
- Cheah, Chan Y
- Carney, Dennis A
- Prince, H Miles
- Wolf, Max
- Bazargan, Ali
- Januszewicz, E Henry
- Filshie, Robin
- Westerman, David
- Seymour, John F
- Tam, Constantine S
Producer: 20170106
In:
Leukemia & lymphoma vol. 57
Availability: No items available.
|
|
|
6253.
|
|
|
|
6254.
|
|
|
|
6255.
|
|
|
|
6256.
|
Risk factors for late-onset neutropenia after rituximab treatment of B-cell lymphoma. [electronic resource] by
- Arai, Yasuyuki
- Yamashita, Kouhei
- Mizugishi, Kiyomi
- Nishikori, Momoko
- Hishizawa, Masakatsu
- Kondo, Tadakazu
- Kitano, Toshiyuki
- Kawabata, Hiroshi
- Kadowaki, Norimitsu
- Takaori-Kondo, Akifumi
Producer: 20160115
In:
Hematology (Amsterdam, Netherlands) vol. 20
Availability: No items available.
|
|
|
6257.
|
Pilot study of 19 patients with severe pemphigus: prophylactic treatment with rituximab does not appear to be beneficial. [electronic resource] by
- Gregoriou, S
- Giatrakou, S
- Theodoropoulos, K
- Katoulis, A
- Loumou, P
- Toumbis-Ioannou, E
- Papadavid, E
- Avgerinou, G
- Stavrianeas, N
- Rigopoulos, D
Producer: 20141223
In:
Dermatology (Basel, Switzerland) vol. 228
Availability: No items available.
|
|
|
6258.
|
|
|
|
6259.
|
|
|
|
6260.
|
|